Benign ovarian tumours

7,514 views 77 slides Jan 27, 2021
Slide 1
Slide 1 of 77
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52
Slide 53
53
Slide 54
54
Slide 55
55
Slide 56
56
Slide 57
57
Slide 58
58
Slide 59
59
Slide 60
60
Slide 61
61
Slide 62
62
Slide 63
63
Slide 64
64
Slide 65
65
Slide 66
66
Slide 67
67
Slide 68
68
Slide 69
69
Slide 70
70
Slide 71
71
Slide 72
72
Slide 73
73
Slide 74
74
Slide 75
75
Slide 76
76
Slide 77
77

About This Presentation

Benign ovarian masses include functional cysts and tumors; most are asymptomatic.Most functional cysts and benign tumors are asymptomatic. Sometimes they cause menstrual abnormalities. Hemorrhagic corpus luteum cysts may cause pain or signs of peritonitis, particularly when they rupture. Occasionall...


Slide Content

BENIGN OVARIAN TUMOURS Dr. NIRANJAN CHAVAN Professor & Unit Chief LTMMC & LTMGH Hospital , Sion, Mumbai -22 Chairperson, FOGSI Oncology & TT Committee.(2012-2014) Convener & Chair, FOGSI –Violence against Doctor Cell (2015-2016) Member, Oncology Committee AOFOG (2013-2015) Managing Committee Member ,AFG & IAGE Editor-AFG Times Newsletter Director, Chavan Maternity & Nursing hOME J.P. Road, Andheri West, Mumbai 53

NORMAL OVARIES Normal size 5 x 3 x 3cm Variation in dimensions can result from Endogenous hormonal production(varies with age and menstrual cycle) Exogenous substances, including OCs, GnRH agonists, or ovulation-inducing medication, may affect size.

Benign Ovarian Tumours Epidemiology Embryology E tiology Risk factors WHO classification Pathology of ovarian tumours Management (diagnosis & management) Surgery

Embryology of the ovary Primitive gonads appear around the 5 th week of IUL as the gonadal ridge from the coelomic epithelium on the medial aspect of the urogenital ridge. In the xx embryo , the cortex develop as the ovary and the medulla regress to a small area. The ovarian serosa is the direct descent of the coelomic epithelium and it give rises to endocervical,endometrial,endosalphinx and the epithelium of the urogenital system. The undifferentiated serosal cells can undergo neoplastic changes and lead to tumours of the above tissues.

►FOLLICULAR CYST ►CORPUS LUTEUM CYST ►THECA LUTEIN CYST ►TUBO OVARIAN ABSCESS ►BENIGN ►BORDERLINE ►MALIGNANT ►ENDOMETRIOMA ►ENLARGED PCO ►PAROVARIAN CYST

(I) Functional (II) Inflammatory (III) Others (IV) Neoplastic (1) Germ cell (2) Epithelial (3)Sex cord stromal (a) Follicular cyst (b) Corpus Luteal cyst (c) Theca Luteal cyst Tubo -ovarian abscess ( a) Endometrioma Ovary (a) Benign teratoma / Dermoid Cyst (a) Serous cyst adenoma (b ) Mucinous cyst adenoma (c) Brenner tumour (d) Fibroma Thecoma (a) Granulosa cell , Sertoli - leydig cell CAUSES OF BENIGN OVARIAN CYSTS

OVARIAN TUMOUR SCREENING MULTI MODEL C a 125 and Ultrasound scanning Ca 125 >30 u\ml is abnormal Ca 125 is an antigen found in the foetal amniotic and coelomic epithelium.in adults it is found in mesothelial cells of pleura Pericardium and tubal, endometrial, endocervical and the ovary. The surface epithelium of normal foetal and adult ovaries does not express the antigen , except in inclusion cysts, papillae or metaplasia An elevated level is found in 50% of stage 1 and >90% in women with advanced disease. Sensitivity is 97% Specificity is 96% False positive in ca endometrium ,ca colon, endometriosis, fibroid, PID, pregnancy and menstruation

Classification of ovarian mass 1. Simple cyst 2. Hemorrhagic cyst 3. Hyperstimulation in women who have undergone fertility treatment 4. Luteoma of Pregnancy 5. Endometrioma 6. Brenners tumour 7. Epithelial tumours Serous and mucinous , endometroid and clear cell tumours . 8. Sex cord and Mesenchymal tumours Fibrothecomas , granulosa cell , sclerosing stromal and sertoli-leydig cell tumours . 9. Germ cell tumours Mature and immature teratomas , dysgerminomas , endodermal sinus tumours , embryonal carcinomas.

Functional ovarian cysts Follicular cysts Corpus luteum cysts Theca lutein cysts Luteomas of pregnancy By far the most common clinically detectable enlargements of the ovary in the reproductive years. All are benign and usually asymptomatic.

Follicular cysts Cystic follicle is defined as Follicular cyst of diameter > 3cm Most common functional cysts. Rarely larger than 8cm. Lined by granulosa cells Found incidentally on pelvic examination Usually resolve within 4 – 8 weeks with expectant management May rupture or torse occasionally causing pain and peritoneal symptoms.

Corpus luteal cyst Less common than follicular cyst . May rupture leading to hemoperitoneum and requiring surgical management( more in patients taking anti coagulants or with bleeding diathesis) Unruptured cysts may cause pain because of bleeding into enclosed ovarian cyst cavity.

Corpus luteal cyst

Theca lutein cysts Least common Usually bilateral Result from overstimulation of the ovary by β - hCG Do not commonly occur in normal pregnancy Often associated with hydatidiform moles, choriocarcinoma, multiple gestations, use of clomiphene and GnRH analogues. May be quite large (up to 30 cm) , multicystic, and regress spontaneously.

Theca lutein cysts

Management of functional cysts Expectant Watchful waiting for two or three cycles is appropriate. Combined oral contraceptives appear to be of no benefit. Should cysts persist, surgical management is often indicated. Oral contraceptives for functional ovarian cysts (Review) Cochrane Database of Systematic Reviews 2011

Asymptomatic simple cysts <5cms Likely physiological (do not require follow up ) 5-7 cms Yearly USG >7cm Require further imaging/surgical intervention. RCOG 2011

(I) Functional  (II) Inflammatory (III) Others (IV) Neoplastic (1) Germ cell (2) Epithelial (3)Sex cord stromal (a) Follicular cyst (b) Corpus Luteal cyst (c) Theca Luteal cyst  (a) Tubo -ovarian abscess Endometrioma Ovary (a) Benign teratoma / Dermoid Cyst (a) Serous cyst adenoma (b ) Mucinous cyst adenoma (c) Brenner tumour (d) Fibroma Thecoma (a) Granulosa cell , Sertoli - leydig cell CAUSES OF BENIGN OVARIAN CYSTS

(a) Inflammatory ovarian cysts Tubo-ovarian abscess Are present in 14-38% of patients hospitalized with pelvic inflammatory disease (PID) . Commonly seen in patients with poor access to routine gynecologic care .

The traditional criteria for the diagnosis of PID include subjective bilateral abdominal pain per patient report and positive physical examination findings for bilateral adnexal tenderness at palpation and cervical motion tenderness. A hydrosalpinx is generally anechoic, whereas a pyosalpinx may have increased echoes within the fluid.

(I) Functional (II) Inflammatory  (III) Others (IV) Neoplastic (1) Germ cell (2) Epithelial (3)Sex cord stromal (a) Follicular cyst (b) Corpus Luteal cyst (c) Theca Luteal cyst Tubo -ovarian abscess  (a) Endometrioma Ovary (a) Benign teratoma / Dermoid Cyst (a) Serous cyst adenoma (b ) Mucinous cyst adenoma (c) Brenner tumour (d) Fibroma Thecoma (a) Granulosa cell , Sertoli - leydig cell CAUSES OF BENIGN OVARIAN CYSTS

(A) Endometrioma of ovary Most common site of involvement is the ovary. Endometriomas are pseudocysts formed by invagination of the ovarian cortex, sealed off by adhesions. They may completely replace normal ovarian tissue. Cyst walls are usually thick and fibrotic.

USG : anechoic cysts to cysts with diffuse low-level echoes to solid-appearing masses. Fluid–fluid or debris–fluid levels may also be seen . They may be unilocular or multilocular with thin or thick septations Malignant transformation: 0.3% to 0.8% Management: medical and/ or surgical

Chocolate cyst of Ovary on cut section Ovarian Endometrioma

(I) Functional (II) Inflammatory (III) Others  (IV) Neoplastic (1) Germ cell (2) Epithelial (3)Sex cord stromal (a) Follicular cyst (b) Corpus Luteal cyst (c) Theca Luteal cyst Tubo -ovarian abscess (a) Endometrioma Ovary (a) Benign teratoma / Dermoid Cyst (a) Serous cyst adenoma (b ) Mucinous cyst adenoma (c) Brenner tumour (d) Fibroma Thecoma (a) Granulosa cell , Sertoli - leydig cell CAUSES OF BENIGN OVARIAN CYSTS

Benign ovarian tumors Serous cystadenoma Mucinous cystadenoma Dermoid cyst Fibroma Thecoma Brenner’s tumor

(A) SEROUS CYSTADENOMA Generally benign Bilateral – 10% Risk of malignancy : 5 – 10 % borderline malignant, 20 -25% malignant GROSS : multilocular with papillary components. MICRO : low columnar epithelium with cilia. Characteristic psammoma bodies (end products of degeneration of papillary implants)are found. Associated fibrosis may lead to “ cystadenofibroma ”

On USG Serous Cystadenoma Gross appearance Gross appearance Cut section appearance Cut section appearance

On MRI Serous Cystadenoma On USG Serous Cystadenoma

(B) MUCINOUS CYSTADENOMA Have tendency to become huge masses Gross : Round to ovoid masses with smooth capsules that are usually translucent or bluish to whitish gray. Interior divided by discrete septa into loculi containing clear , viscid fluid. Microscopy : Epithelium – tall, pale staining, secretary with basal nuclei and goblet cells 5 – 10% are malignant

Epithelium – tall, pale staining, secretary with basal nuclei and goblet cells

On MRI Mucinous cystadenoma.

DERMOID CYST/ Benign cystic teratoma Often bilateral (15 -25%) GROSS : thick, opaque , whitish wall. CONTENTS: hair, bone, cartilage, and a large amount of greasy sebaceous material. MICROSCOPICALLY : all the three germ layers (ectoderm, mesoderm and endoderm) Malignant change occurs in 1-3%. Usually of a squamous type. Risk of torsion is 15% An ovarian cystectomy is almost always possible, even if it appears that only a small amount of ovarian tissue remains

Dermoid Cyst ( Benign Cystic Teratoma )

FIBROMA Most common benign, solid neoplasms of the ovary. Compose approx 5% of benign ovarian neoplasms and 20% of all solid tumors of the ovary. Frequently seen in middle-aged women. Characterized by their firmness and resemblance to myomas Misdiagnosed as exophytic fibroids or primary ovarian malignancy Not hormonally active Fibromas may be associated with ascites or hydrothorax as a result of increased capillary permeability thought to be a result of VEGF Mieg’s syndrome (ovarian fibromas, ascites and hydrothorax) is uncommon and usually resolves after surgical excision.

OVARIAN FIBROMA Microscopy .. Gross appearance

On MRI Ovarian F ibroma .

THECOMA Solid fibromatous lesions that show varying degrees of yellow or orange discoloration Almost always confined to one ovary Usually >40 years, 65% after menopause May be hormonally active and hence associated with estrogenic or occasionally androgenic effects. Luetinised thecoma – younger, sclerosing peritonitis and ascites Leydeig cell thecoma – associated with Reinke crystals Rarely malignant

BRENNER TUMOR It is named for Fritz Brenner, who characterized it in 1907. The term "Brenner tumor " was first used by Robert Meyer, in 1932. Uncommon tumor grossly identical to fibroma . Arise from Walthard cell rests ,also from surface epithelium, rete ovarii and ovarian stroma . Brenner tumors are usually found incidentally at pathologic evaluation, often in conjunction with a mucinous cystadenoma or dermoid cyst. They are relatively rare tumors and are most common in the fifth to sixth decades of life.

On microscopy – markedly hyperplastic fibromatous matrix interspersed with nests of epitheloid cells showing coffee bean pattern Considered uniformly benign. But scattered reports of malignant Brenner’s available Endocrinologically inert, but could be ass. with virilization and endometrial hyperplasia Cut section Microscopy

Ovarian Gonadal Sex Cord Stromal Tumours Granulose theca cell tumours Sertoli-Leydig cell tumours

Found in all age groups and associated with the pseudo precocious puberty. Early breast development , menstrual disorders, postmenopausal vaginal bleeding make up the characteristic symptom. Laboratories studies demonstrate an increase in the number of mature epithelial cells in the vaginal cytologic specimen, elevated urinary and serum estrogen levels and varirant degree of endometrial proliferation. Microscopy : The characteristic cell is the round or slightly ovoid granulosa cell with its dark nucleus. Mitosis are common and the ovumlike “Call Exner bodies “ are classic. Granulosa stromal Sex cord tumours

Sertoli Leydig cell Tumours Also called as Androblastoma Often affect females beneath the ages of 40yrs Usually be luteinised, simulating the classic pattern of the testes and producing steroids Generally benign, may produce the masculinisation.

TREATMENT OF NEOPLASTIC TUMOURS In most instances, simple excision of the solid tumors is adequate therapy, particularly for women of reproductive age.

CLINICAL PRESENTATION Asymptomatic – accidentally discovered on USG Chronic pattern of pain, increasing abdominal girth over months or weeks. Associated with secondary symptoms of anorexia, nausea, vomiting, urinary frequency. Could be associated with primary or secondary amenorrhea, menstrual irregularities, virilization, precocious puberty Become acutely symptomatic if undergoes torsion, rupture or haemorrhage. Benign ovarian neoplasms are indistinguishable clinically from malignant counterparts

Age : late child bearing age dermoid , mucinous adenoma common in reproductive age dermoid common in pregnancy Symptoms Asymptomatic , detected accidently during routine abdominal or gynecological examinations or during laporoscopic or laparotomy . Nonspecific symptoms like Feeling of abdominal distension and vague discomfort. Features of dyspepsia such as flatulence and eructations . Gradually more pronounced symptoms appear like Abdominal swelling which may be rapid Dull abdominal pain Respiratory distress which may be mechanical due to ascites /pleural effusion. Menstrual abnormalities in functioning ovarian tumours. For other ovarian tumours symptoms may differ eg . Androblastoma - Hirsutism . Signs General condition usually remains unaffected. The patient may be cachectic due to protein loss in huge mucinous cyst adenoma. CLINICAL PRESENTATION

On abdominal examination Inspection Bulge of lower abdomen over which abdominal wall moves freely with respiration. The mass may fill the entire abdominal cavity everting the umbilicus with visible veins under the skin.the flanks remain flat. Mass is cystic or solid. Palpation Surface is smooth ,non tender and freely mobile from side to side but restricted from above downwards unless pedicle is long. upper and latearal borders are well defined bt the lower pole is difficult to reach. Percussion dull in centre and resonants in the flanks. A fluid thrill may be elicited when the wall are thin and the content is watery. A friction rub may be present over the tumour. Bimanual Pelvic examination Uterus seperate from the mass groove present between uterus and the mass movement of the mass p/a fails to move the cervix lower pole of the cyst felt through the fornix absence of pulsation of uterine vessels through the fornix

COMPLICATIONS Of Benign ovarian tumours Torsion : Commonly seen in Dermoid cyst, serous cystadenoma . Intracystic hemorrhage : serous Cystadenoma , venous congestion. Infection : Following torsion. Rupture : Big and tense type,following trauma. Pseudomyxoma peritonei : Seen in Mucinous Cystadenoma Intestinal Obstruction Malignancy : Rare .

MANAGEMENT

TransVaginal ultraSound Pattern recognition is superior to all other scores. Subjective evaluation of ovarian masses based on pattern recognition can achieve sensitivity of 88% to 100% and specificity of 62% to 96%. Adding doppler does not seem to yield much improvement in the diagnostic precision, but increases the confidence with which a correct diagnosis of benignity or malignancy is made.

simple ultrasound-based rules for the diagnosis of ovarian cancer. ultrasound obstetgynecol2008 RCOG 2011

DOPPLER EVALUATION Hypoxic tissue in tumors recruit low-resistance, high-flow blood vessels Role in evaluating ovarian mass is controversial – as the ranges of values of RI,PI,MSV between benign and malignant masses overlap. PI<1, RI<0.4 To overcome this, vascular sampling of suspicious areas (papillary projections, solid areas, thick septations) using both 3D USG and power doppler both has been evaluated and found effective.

OTHER IMAGING MODALITIES CT, MRI, PET not recommended in the initial evaluation CT scan: evaluating LN involvement, Omental mets, peritoneal deposits, hepatic mets, obstructive uropathy or a probable alternate primary site when cancer is suspected based upon TVS MRI : differentiating non adnexal pelvic masses (like leiomyomata), expensive and inconvenient. ACOG GUIDELINES 2007

TUMOR MARKERS CA125 CEA CA 19-9 HE4

SENSITIVITY SPECIFICITY PPV NPV 61-90% 71-93% 35-91% 67-90% CA125 Most useful when non-mucinous epithelial cancers are present Elevated in 80% of patients with epithelial ovarian Ca but only in 50% of patients with stage I disease Increased sensitivity in post menopausal women esp. when associated with relevant clinical and USG findings Cut-off of 30 u/ml, sensitivity of 81% and specificity of 75%

Levels higher than 5 mg/ Lare seen in 85-90% of mucinous tumours but only in 30% of other epithelial cancers. CEA It is elevated in mucinous ovarian malignancy. CA 19.9

HE4 HE4 is a precursor to the epididymal secretory protein E4 and in normal ovarian tissue, there is minimal gene expression and production of HE4. HE4 when studied in the premenopausal group of patients was able to discriminate benign tumors from malignancies As a single tumor marker, HE4 had the highest sensitivity for detecting ovarian cancer, especially Stage I disease. Combined CA125 and HE4 is a more accurate predictor of malignancy than either alone or to any other dual combination of markers HE4 levels(>70 pM ) were found to be elevated in over half of the patients with ovarian cancer with normal serum CA125 levels (>35 U/ml) Moore et al. / Gynecologic Oncology, 2008

Benign Ovarian tumour Malignant Ovarian tumour Common in middle age group Painless unless compicated No edema No varicosities Generally unilateral Unilocular Thin walled Thin septae if present No papillae or solid contents Normal or decreased vascularity on doppler No metastasis Slow growing Smooth, cystic Freely mobile No ascites or if present clear fluid on paracentesis Seen at extremes of ages May be painful Edema maybe present Varicosities may be present May be bilateral Multilocular Thick walled Thick septae Mixed echogenicity High vascularity , low pulsatility index and low resistance index Metastasis in advanced disease Rapidly growing Solid, nodular, irregularly shaped Fixed Ascites present and on paracentesis the fluid may be blood stained.

Treatment

INDICATIONS FOR SURGERY Any solid ovarian lesion Any ovarian lesion with papillary vegetation on the cyst wall Any adnexal mass >10cm in diameter Palpable adnexal mass in a premenarchal or postmenopausal women Torsion or rupture suspected

Ovarian mass in reproductive age group <5 cms . >/= 5 cms USG USG cystic observation Complex, solid, suspicious Persistence or progression surgery

CYST ASPIRATION Diagnostic cytology has poor sensitivity to detect malignancy, ranging from 25% to 82% Not therapeutic, even when a benign mass is aspirated Approx. 25% of cysts will recur within 1 year Aspiration of a malignant mass may induce spillage and seeding of cancer cells into the peritoneal cavity.

OPERATIVE MODALITIES Laparoscopy vs laparotomy – decision based on suspicion of malignancy and technical expertise No RCTs comparing recurrence rates following laparoscopy or laparotomy. The objective is to try cystectomy if possible. Laparoscopic surgery for benign ovarian tumours is associated with less pain, shorter hospital stay, and fewer adverse events than with laparotomy. Cochrane Database of Systematic Reviews 2009

SURGERY Young women : Ovarian cystectomy Oophorectomy ( salpingo ophorectomy ) Parous women : Total Abdominal Hysterectomy with Bilateral ophorectomy Others : Individualisation

The standards for laparoscopy in benign tumours careful examination of the external surface of the tumour and sampling of the peritoneal cavity avoidance of any tumoral rupture protection of the ovarian tumour with an endoscopic bag before removal

ROLE OF FROZEN SECTION The diagnostic accuracy of frozen section analysis is high for malignant and benign ovarian tumours, but accuracy is poor in the case of borderline ovarian tumors. Medeiros 2005

Conclusion Ovarian masses are very commomly seen in general population.Most of the times these are simple functional tumours which resolve spontaneously within six to eight weeks.However an indepth understanding of the ovarian masses is needed as th the grave consequences that may follow if there is a wrong diagnosis.Imaging studies especially ultrasound is a prime tool in diagnosing ovarian tumours. Careful consideration to woman’s need should be addresses before selecting any method of treatment .